跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
TEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
TEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Merck Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2022
Approval ID
767440527735f7af
Company
Merck Europe B.V.
Type
Standard
Approval Details
Approval Id
767440527735f7af
Drug Cima Aemps Name
TEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211596001
Holder Company Name
Merck Europe B.V.
Marketing Company Name
Merck S.L.
Holder Company Detail Path
/organization/merck-europe-bv
Authorization Date
2022-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
225 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Merck Europe B.V.
Company Detail Path
/organization/merck-europe-bv
Company Information
Pharmaceutical Company Name
Merck Europe BV
Country Name
Netherlands
Active Ingredients
TEPOTINIB HIDROCLORURO MONOHIDRATO
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2022
Approval ID
767440527735f7af
Type
Standard
Back to CIMA-AEMPS Approvals
TEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
